{Reference Type}: Journal Article
{Title}: A review of nuclear Dbf2-related kinase 1 (NDR1) protein interaction as promising new target for cancer therapy.
{Author}: Lu J;Feng Y;Yu D;Li H;Li W;Chen H;Chen L;
{Journal}: Int J Biol Macromol
{Volume}: 259
{Issue}: 0
{Year}: 2024 Feb 4
{Factor}: 8.025
{DOI}: 10.1016/j.ijbiomac.2023.129188
{Abstract}: Nuclear Dbf2-related kinase 1 (NDR1) is a nuclear Dbf2-related (NDR) protein kinase family member, which regulates cell functions and participates in cell proliferation and differentiation through kinase activity. NDR1 regulates physiological functions by interacting with different proteins. Protein-protein interactions (PPIs) are crucial for regulating biological processes and controlling cell fate, and as a result, it is beneficial to study the actions of PPIs to elucidate the pathological mechanism of diseases. The previous studies also show that the expression of NDR1 is deregulated in numerous human cancer samples and it needs the context-specific targeting strategies for NDR1. Thus, a comprehensive understanding of the direct interaction between NDR1 and varieties of proteins may provide new insights into cancer therapies. In this review, we summarize recent studies of NDR1 in solid tumors, such as prostate cancer and breast cancer, and explore the mechanism of action of PPIs of NDR1 in tumors.